Inhibition by anticonvulsants of prostate-specific antigen and interleukin-6 secretion by human prostate cancer cells.
about
Therapeutic Value of Voltage-Gated Sodium Channel Inhibitors in Breast, Colorectal, and Prostate Cancer: A Systematic ReviewVoltage-gated ion channels in cancer cell proliferationSodium channel-inhibiting drugs and cancer survival: protocol for a cohort study using the CPRD primary care databaseInverse Association between Sodium Channel-Blocking Antiepileptic Drug Use and Cancer: Data Mining of Spontaneous Reporting and Claims Databases.The neonatal splice variant of Nav1.5 potentiates in vitro invasive behaviour of MDA-MB-231 human breast cancer cells.The sodium channel-blocking antiepileptic drug phenytoin inhibits breast tumour growth and metastasis.An emerging role for voltage-gated Na+ channels in cellular migration: regulation of central nervous system development and potentiation of invasive cancersTherapeutic potential for phenytoin: targeting Na(v)1.5 sodium channels to reduce migration and invasion in metastatic breast cancer.Sodium channel-inhibiting drugs and survival of breast, colon and prostate cancer: a population-based studyVoltage-gated sodium channels and metastatic disease.The effects of anesthetics on tumor progression.Dual roles of voltage-gated sodium channels in development and cancer.Voltage-gated sodium channel as a target for metastatic risk reduction with re-purposed drugs.Eicosapentaenoic acid inhibits voltage-gated sodium channels and invasiveness in prostate cancer cells.Activity-dependent regulation of voltage-gated Na+ channel expression in Mat-LyLu rat prostate cancer cell line.Epidermal growth factor upregulates motility of Mat-LyLu rat prostate cancer cells partially via voltage-gated Na+ channel activity.
P2860
Q26772803-21F00257-24DB-4E50-9351-0E50350BB484Q27010511-A15BDBAD-A87E-4572-8308-8967D481B9F8Q28595847-40D9B363-9658-4BD2-B6CB-E53F50E445D1Q31040399-21D4ECD1-B80C-4285-9949-933FD4AB5B70Q34006958-338843D3-0A86-4E5B-AC53-E3CFD5BD3D29Q35061372-C7582D07-D09D-4F48-9338-DE37A7C780A2Q36049612-0DB37318-1A1B-4BA9-ADB5-654B9319489BQ36107167-E77C1612-9C40-4681-B80B-282A1068CB55Q36291060-36FC4256-B2E2-4B6D-9EB2-0104D7635FAFQ36430239-910ACBD7-5238-4AA3-80DD-CEFCDD84A56FQ38092641-7BAD4B93-17DB-47D1-B846-D674443AFE74Q38502153-4EACF457-5A63-4960-B666-549F64AA0B9BQ38894913-E3682067-6CEE-43D1-815E-279896F44080Q39893348-5512489B-D42F-48DC-8A58-939F8ACAA2CAQ40303566-9B848F80-B568-44CC-B0C7-B262E49AB494Q42771284-2821B5B2-F57F-4C50-ABDB-49458531AA20
P2860
Inhibition by anticonvulsants of prostate-specific antigen and interleukin-6 secretion by human prostate cancer cells.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Inhibition by anticonvulsants ...... y human prostate cancer cells.
@en
Inhibition by anticonvulsants ...... y human prostate cancer cells.
@nl
type
label
Inhibition by anticonvulsants ...... y human prostate cancer cells.
@en
Inhibition by anticonvulsants ...... y human prostate cancer cells.
@nl
prefLabel
Inhibition by anticonvulsants ...... y human prostate cancer cells.
@en
Inhibition by anticonvulsants ...... y human prostate cancer cells.
@nl
P1433
P1476
Inhibition by anticonvulsants ...... y human prostate cancer cells.
@en
P2093
P304
P407
P577
2001-05-01T00:00:00Z